A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma
- 15 February 1992
- Vol. 69 (4) , 878-882
- https://doi.org/10.1002/1097-0142(19920215)69:4<878::aid-cncr2820690407>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicityCancer, 1990
- Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.Journal of Clinical Oncology, 1990
- Interferon effects upon fluorouracil metabolism by HL-60 cellsBiochemical and Biophysical Research Communications, 1989
- Triazinate and Platinum Efficacy in Combination With 5-Fluorouracil and Doxorubicin: Results of a Three-Arm Randomized Trial in Metastatic Gastric CancerJNCI Journal of the National Cancer Institute, 1988
- Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study.Journal of Clinical Oncology, 1984
- Randomized study of combination chemotherapy in unresectable gastric cancerCancer, 1984
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- Integration of chemotherapy into combined modality treatment of solid tumors: III. Gastric cancerCancer Treatment Reviews, 1974